- Home
- SCNI vs PBM Comparison
SCNI vs PBM Comparison
Compare SCNI & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNI
- PBM
- Stock Information
- Founded
- SCNI 2003
- PBM 1994
- Country
- SCNI Israel
- PBM Canada
- Employees
- SCNI N/A
- PBM N/A
- Industry
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- PBM
- Sector
- SCNI Health Care
- PBM
- Exchange
- SCNI Nasdaq
- PBM NYSE
- Market Cap
- SCNI 3.5M
- PBM 4.0M
- IPO Year
- SCNI N/A
- PBM N/A
- Fundamental
- Price
- SCNI $2.84
- PBM $0.05
- Analyst Decision
- SCNI
- PBM
- Analyst Count
- SCNI 0
- PBM 0
- Target Price
- SCNI N/A
- PBM N/A
- AVG Volume (30 Days)
- SCNI 12.9K
- PBM 8.8M
- Earning Date
- SCNI 11-29-2024
- PBM 11-29-2024
- Dividend Yield
- SCNI N/A
- PBM N/A
- EPS Growth
- SCNI N/A
- PBM N/A
- EPS
- SCNI N/A
- PBM N/A
- Revenue
- SCNI $284,000.00
- PBM N/A
- Revenue This Year
- SCNI N/A
- PBM N/A
- Revenue Next Year
- SCNI N/A
- PBM N/A
- P/E Ratio
- SCNI N/A
- PBM N/A
- Revenue Growth
- SCNI N/A
- PBM N/A
- 52 Week Low
- SCNI $2.23
- PBM $0.05
- 52 Week High
- SCNI $8.92
- PBM $14.55
- Technical
- Relative Strength Index (RSI)
- SCNI 30.31
- PBM 27.59
- Support Level
- SCNI $2.91
- PBM $0.06
- Resistance Level
- SCNI $3.70
- PBM $0.06
- Average True Range (ATR)
- SCNI 0.21
- PBM 0.01
- MACD
- SCNI -0.07
- PBM 0.00
- Stochastic Oscillator
- SCNI 7.37
- PBM 1.07
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.